Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole Monotherapy vs Paclitaxel/Carboplatin and Maintenance Letrozole in Low-Grade Serous Ovarian Cancer
NCT04095364Phase 3Active, not recruiting
- Sponsor
- NRG Oncology
- Start
- Sep 2019
- Primary completion
- Feb 2027
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of letrozole in Low grade serous ovarian cancer (LGSOC), fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by NRG Oncology. Started Sep 2019; status: active, not recruiting.
02
Drugs
letrozole
03
Conditions
Low grade serous ovarian cancer (LGSOC)fallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT04095364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04095364.